Haemonetics Corp. acquired Vivasure Medical Ltd. for €100 million (US$116.36 million) cash plus up to an additional €85 million in contingent payments based on sales and other milestones. In 2023, Haemonetics invested €30 million in Vivasure as part of its series D financing round.

Vicentra secures additional $13M for Kaleido insulin patch pump

Investors poured a further $13 million into Vicentra BV for Kaleido, its insulin patch pump system, taking the total raised in the company’s series D financing round to $98 million. The funds come amid significant changes across diabetes technology, particularly the acceleration of patch pumps. Kaleido is one of the smallest, lightest, and most precise insulin patch pumps available.

OpenAI’s GPT Health nudges AI closer to FDA regulatory divide

Generative AI has largely escaped the U.S. FDA’s regulatory purview up to now, but OpenAI seems poised to create a new source of regulatory angst for the agency. The company unveiled its ChatGPT Health Jan. 7, a large language model that when used professionally could land the company in the FDA’s regulatory crosshairs.

China’s slashes tariffs on some medical devices

Beginning Jan. 1, China will apply provisional import tariff rates lower than the most-favored-nation rates on 935 items, the State Council announced. The move aims to boost collaboration between domestic and international sectors, and to leverage resources of both to expand the supply of high-quality goods. “The latest reductions focus on both advanced medical devices and diagnostic inputs, reflecting an emphasis on improving access to high-quality treatment and disease detection,” Dezan Shira and Associates said in a recent briefing. These reductions signal a continued policy focus on lowering the cost of advanced medical technologies and critical diagnostics.

December IPOs power rebound year for med-tech financing

Med-tech financing activity rebounded sharply in 2025, with total capital raised climbing to $39.55 billion, nearly doubling from $25.35 billion in 2024 and approaching pre-pandemic norms. The increase was driven primarily by a surge in IPO activity, which reached $13.01 billion. Medline Inc. led December’s five med-tech IPOs with a $6.26 billion public offering, reportedly the largest IPO globally in 2025.

Patent for wearable speech-sensing device filed

Jun Chen, a tenured associate professor of bioengineering at the Samueli School of Engineering at the University of California Los Angeles (UCLA), leads a team developing a speech-sensing wearable patch. The technology translates the intricate muscle movements of the larynx into discernible speech.

Chen filed for patent protection of the assistive device that could aid in restoring speech to those suffering from damaged or dysfunctional vocal cords. Chen and Wearable Bioelectronics Research Group at UCLA previously published findings in Nature Communications.

Also in the news

Accustem Sciences, Aetna, Apella, Armonica Technologies, Bertelsmann India Investments, Daisy Genomics, Elucid, Femhealth Ventures, Fineheart, Heartflow, Illumina, Inito, Koelis, Labcorp, MD Anderson, New Day Diagnostics, Omada Health, Pomelo Care, Premia, Quest Diagnostics, Sanara Medtech, Siemens Healthineers, Skyline, Starmed, Surf Therapeutics, Visby, Welldoc